Helsinki Lopid study
Executive Summary
Five-year study to evaluate efficacy of the lipid lowering agent in preventing heart attack has been completed. "The data generated by the study are currently being analyzed and final results will be published in a refereed medical journal late this summer," Warner-Lambert said.